The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Dupilumab for bullous pemphigoid induced by immune checkpoint inhibitors.
 
Ian Nykaza
No Relationships to Disclose
 
Stephen Dusza
No Relationships to Disclose
 
Gopa Iyer
Consulting or Advisory Role - AstraZeneca; Bicycle Therapeutics; Flare Therapeutics; Janssen; Loxo/Lilly; Mirati Therapeutics
Research Funding - AADi (Inst); Flare Therapeutics (Inst); Janssen (Inst); Loxo/Lilly (Inst); Pfizer (Inst)
 
Alina Markova
Consulting or Advisory Role - ADC Therapeutics, Alira Health, Protagonist Therapeutics, OnQuality, and Janssen
Research Funding - Amryt Pharma, Incyte Corporation, Janssen, Kintara Therapeutics, Novartis, Novocure, NIH U01, NIH U54, NIH/NCI Cancer Center Support Grant P30- CA008748
Patents, Royalties, Other Intellectual Property - UpToDate